Your new experience awaits. Try the new design now and help us make it even better

COMMUNITY CASE STUDY article

Front. Psychiatry

Sec. Anxiety and Stress Disorders

This article is part of the Research TopicBridging the Gap: An Interdisciplinary Perspective on Ketamine in Psychiatric Disorders - Volume IIIView all 9 articles

Evidence in Practice: Implementing KAT in Indigenous Health Services

Provisionally accepted
Jean Jacque  Emile LovelyJean Jacque Emile Lovely1*Hiedi  YardleyHiedi Yardley1Reverdi  DardaReverdi Darda1Quintina  Bearchief-AdolphoQuintina Bearchief-Adolpho2Lisa  KempLisa Kemp1Charlene  BroughCharlene Brough2Vanessa  DooreVanessa Doore2Jennifer  KohlhammerJennifer Kohlhammer2Andrew  CharretteAndrew Charrette3
  • 1ATMA CENA Psychedelic Healthcare Solutions, Edmonton, Canada
  • 2Siksika Health Services, Siksika, Canada
  • 3KGK Science, London, Canada

The final, formatted version of the article will be published soon.

Ketamine-Assisted Therapy (KAT) presents a promising alternative for addressing mental health challenges, particularly in treatment-resistant conditions, yet little exists in the literature guiding its implementation in an Indigenous context, for Indigenous participants, or describing culturally adapted delivery models. This paper presents insights and lessons learned from a collaborative pilot program between Siksika Health Services and ATMA CENA to design and deliver a culturally responsive KAT program within the Siksika First Nation in Alberta Canada. The initiative aimed to explore the feasibility and therapeutic impact of KAT in an Indigenous healthcare setting, while also being conscious of cultural relevance and opportunities for continued clinical and quality improvement of the program. The pilot followed a five-phase approach: collaboration, knowledge acquisition, lived experience, data collection, and follow-up. Recruitment resulted in 6 participants competing care (3 Indigenous and 3 non-Indigenous). Findings demonstrated notable improvements in symptoms of depression, anxiety, and PTSD, with participants reporting increased emotional regulation and stronger cultural connections. Cultural elements including shared meals, traditional decor and blankets, community orientation, and a mid-program break for cultural events, were central to participant reported safety, trust, and meaning making. Notably, the Indigenous and non-Indigenous participant groups, who were treated together, reported comparable gains in safety, trust, and mental, emotional, and spiritual well-being. These shared outcomes suggest the model may hold relevance for reducing inequities in group KAT delivery. Challenges and lessons learned included need to address stigma and systemic influences experienced by Indigenous participants, barriers affecting timely intention setting and integration therapy, and overcoming logistical barriers when working in rural First Nation environments. This pilot program implementation underscores the importance of culturally responsive mental health interventions and highlights key considerations for expanding psychedelic-assisted therapies in Indigenous communities.

Keywords: culturally integrated care, evidence in practice, Indigenous mental health, ketamine assisted therapy, psychedelic assisted therapy

Received: 13 Oct 2025; Accepted: 10 Feb 2026.

Copyright: © 2026 Lovely, Yardley, Darda, Bearchief-Adolpho, Kemp, Brough, Doore, Kohlhammer and Charrette. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jean Jacque Emile Lovely

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.